ClinicalTrials.gg
CompletedNCT00702832Updated Dec 9, 2019

Effect of Vestibular Rehabilitation - a Randomized Controlled Trial

An interventional study of Vestibular rehabilitation and standard treatment in Dizziness, Nausea and Nystagmus, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-12-09.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2008, registered Jun 2008).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this study is to assess if early supported vestibular rehabilitation can reduce dizziness and improve daily life activities in patients with acute vestibular injury.

The study question is: Does early supported vestibular rehabilitation have an additional effect on dizziness symptoms and daily life functions compared to standard treatment?

02

Conditions studied

  • Dizziness
  • Nausea
  • Nystagmus
  • Vestibular Diseases

Keywords

  • Vestibular rehabilitation
  • acute vestibular injury
  • Dizziness
  • Nausea
  • Nystagmus
  • Daily life activities
  • Balance
  • physiotherapy
03

In context

Dizziness

226 studies on the registry are indexed under Dizziness; 56 are open to participants now.

This study's enrollment of 54 is above the median of 43 across 170 interventional studies indexed under Dizziness.

Browse Dizziness studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • acute symptoms of dizziness, nausea and nystagmus
  • diagnosed by videonystagmography (at least 25% reduced caloric response in one ear)
  • age 18-70 years
  • inclusion within one week after symptom debut

Exclusion Criteria:

  • chronic dizziness
  • psychiatric diagnosis that might interfere with participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Vestibular rehabilitation

    early supported vestibular rehabilitation

    Behavioral: Vestibular rehabilitation

  • Active comparator
    standard

    standard treatment

    Other: standard treatment

Interventions

  • BehavioralVestibular rehabilitation

    Daily home training (4-6 specific exercises) 2-3 times per day. Group training led by a physiotherapist twice per week during the first 10 weeks and once per week from 10 weeks to 12 months or to symptoms are cured.

  • Otherstandard treatment

    treatment as usual

06

What researchers measure

Primary outcomes

  1. vertigo

    Vertigo symptom scale (VSS)

    Time frame: at inclusion, 10-12 weeks, 12 months

Secondary outcomes

  1. Dizziness

    Dizziness Handicap Inventory (DHI), University of California Los Angeles Dizziness Questionnaire (UCLA-DQ), Three questions regarding dizziness on VAS-scale,

    Time frame: At inclusion, 10-12 weeks, 12 months

  2. Movement provoked dizziness

    Rombergs test and advanced Rombergs test

    Time frame: at inclusion, 10-12 weeks, 12 months

  3. return of symptoms

    Time frame: 12 months

  4. sick leave

    Time frame: 12 months

07

Study locations

1 site
  • St. Olavs Hospital
    Trondheim, 7489, Norway
08

References and documents

Publications

  • Tokle G, Morkved S, Brathen G, Goplen FK, Salvesen O, Arnesen H, Holmeslet B, Nordahl SHG, Wilhelmsen KT. Efficacy of Vestibular Rehabilitation Following Acute Vestibular Neuritis: A Randomized Controlled Trial. Otol Neurotol. 2020 Jan;41(1):78-85. doi: 10.1097/MAO.0000000000002443. PubMed 31789800 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2008 to primary completion in Dec 2011, 47 months.

Of 82 non-industry interventional studies with no phase under Dizziness, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 47 months is above that.

Counting every sponsor, half of 90 studies reached it within 20 months; a quarter within 8 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2008
First posted
Jun 20, 2008
StartActual
Jan 2008
Primary completionActual
Dec 2011
CompletionActual
Dec 2011
Last update
Dec 9, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00702832
Responsible party
Sponsor
First posted
Jun 20, 2008
Start date
Jan 2008
Primary completion
Dec 2011
Completion
Dec 2011
Last update
Dec 9, 2019

Study contacts

Siv Mørkved, PhD
principal investigator · Associate professor / senior researcher

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion